BMS-P5 T22277
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
BMS-P5 is a novel Peptidylarginine Deiminase 4 (PAD4) inhibitor that blocks delays progression of multiple myeloma and formation of neutrophil extracellular traps.
CAS nr:
1549811-36-0
Purity:
98%
Molecular Weight:
SMILES:
Formula:
Pathway:
Chromatin/Epigenetic
Target:
PAD
